BioSpace News Archive

Rubraca® (rucaparib) offers a new monotherapy maintenance treatment option for eligible women with platinum-sensitive relapsed ovarian cancer, regardless of BRCA status

Immunovia has published the annual report for 2018 in Swedish.

SilverSneakers®, the nation’s leading community fitness program for older Americans by Tivity Health®, announced a call for nominations for its 2019 Instructor of the Year Awards.

Axonics Modulation Technologies, Inc. announced that Michael H. Carrel has been appointed to the Axonics board of directors, effective immediately.

SpringWorks Therapeutics announced that Saqib Islam, Chief Executive Officer, will present at the Cowen and Company 39th Annual Health Care Conference in Boston on Tuesday, March 12, 2019, at 3:30 p.m. Eastern Standard Time.

Opsens Inc. is pleased to announce the appointment of Mr. Alan Milinazzo as Executive Chairman of the Board of Directors.

COOLIEF* Cooled RF superior to hyaluronic acid injection in a study of knee osteoarthritis patients.

Aurora Cannabis Inc. announced that the Company has completed the acquisition of all the issued and outstanding shares of privately held Whistler Medical Marijuana Corporation, in an all-share transaction, pursuant to the terms of an amalgamation agreement dated January 31, 2019 among Whistler, Aurora, and a wholly owned subsidiary of Aurora.

RecalMax™ is the Twelfth Innovus Pharma Product Approved in Canada to Date

Addition of experienced leadership in GMP Quality as Abzena increases capacity in biologics and complex small molecule manufacturing